Riskpilot← Back to searchSign inGet full accessZiboCare Denmark ApS
APSDissolvedCVR 34483175Præstemarksvej 67Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2012— employees
Revenue 2023
DKK 2,1M
+487% vs 2022
EBITDA margin
100.0%
+487% vs 2022
Equity ratio
46.1%
Financial strength
Net profit 2023
DKK 1,5M
+1431% vs 2022
| Revenue | DKK 2,1M | +487% |
| EBITDA | DKK 2,1M | +487% |
| Net profit | DKK 1,5M | +1431% |
| Total assets | DKK 6,2M | +6% |
| Equity | DKK 2,9M | +111% |
| Employees | — | — |
Legal name
ZiboCare Denmark ApS
CVR number
34483175
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. april 2012
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Address
Præstemarksvej 67
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 433 | 172 | 1.414 | 357 | 2.094 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 433 | 172 | 1.414 | 357 | 2.094 |
| Depreciation & amort. | -74 | -138 | -82 | -198 | -190 |
| EBIT | 359 | 34 | 1.332 | 159 | 1.905 |
| Net financials | -13 | 61 | -142 | -33 | 31 |
| Profit before tax | 346 | 95 | 1.191 | 126 | 1.935 |
| Tax | 44 | 4 | 262 | 28 | 434 |
| Net profit | 302 | 91 | 929 | 98 | 1.501 |
| Item | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2.763 | 5.456 | 8.596 | 5.847 | 6.187 |
| Equity | 235 | 325 | 1.254 | 1.352 | 2.853 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.422 | 4.998 | 7.223 | 4.413 | 3.298 |
| Total debt | 2.422 | 4.998 | 7.223 | 4.413 | 3.298 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202023
Equity ratio
46.1%
This company
38.2%
Market median
+21% vs market
20202023
Return on equity
52.6%
This company
18.4%
Market median
+186% vs market
20202023
Net profit margin
71.7%
This company
8.1%
Market median
+785% vs market
20202023
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20202023
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20202023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-07-01 – 2021-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
JB Chief Executive Officer | Chief Executive Officer | 2018 – 2023 |
CL Management | Management | 2012 – 2018 |
JS Chief Executive Officer | Chief Executive Officer | 2023 – 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 | |
| Company | 100% | 100% | 2016 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2016 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2016 | |
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ZiboCare Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeannette Buchard Denker | Chief Executive Officer | 0 companies |
| Carsten Lau Kjærgård | Management | 0 companies |
| Jesper Skov Rosenbrock | Chief Executive Officer | 0 companies |